TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 39675832

Group type: EXPERIMENTAL
Intervention: Colposcopy with Swedescore
Number of subjects: 586

Group type: COMPARATOR
Intervention: Conventional colposcopy with no Swedescore
Number of subjects: 586
Study: 39675949

Group type: EXPERIMENTAL
Intervention: e-learning program (15 hours over 6 weeks)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 106
Study: 39676137

Group type: EXPERIMENTAL
Intervention: SHR-1701 (30 mg/kg), bevacizumab (7.5 mg/kg), and oxaliplatin (130 mg/m2)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group not specified in the abstract
Number of subjects: 62
Study: 39676465

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment for at least 2 years
Number of subjects: 669
Study: 39676687

Group type: EXPERIMENTAL
Intervention: ESO-101 (mometasone furoate, 800 μg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: ESO-101
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: ESO-101 and Placebo
Number of subjects: 43
Study: 39676868

Group type: EXPERIMENTAL
Intervention: IAH0968 (6 mg/kg, 10 mg/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IAH0968
Number of subjects: 18
Study: 39677358

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: COMPARATOR
Intervention: Both vitamin D and placebo
Number of subjects: 206
Study: 39677360

Group type: EXPERIMENTAL
Intervention: AAP CDA
Number of subjects: 1821

Group type: EXPERIMENTAL
Intervention: BSAC CDA
Number of subjects: 1821

Group type: EXPERIMENTAL
Intervention: NICE NG143 CDA
Number of subjects: 1821

Group type: EXPERIMENTAL
Intervention: Aronson CDA
Number of subjects: 1821

Group type: COMPARATOR
Intervention: Cost comparison of all CDAs vs treat all approach
Number of subjects: 1821
Study: 39677394

Group type: EXPERIMENTAL
Intervention: Oxygen saturation (SpO2) measurement in hospital setting
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Oxygen saturation (SpO2) measurement in follow-up at PHNC
Number of subjects: 357
Study: 39678124

Group type: EXPERIMENTAL
Intervention: Pegloticase + Methotrexate (MTX)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Pegloticase + Placebo (PBO)
Number of subjects: 152
Study: 39678704

Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT-tablet
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1460
Study: 39678839

Group type: EXPERIMENTAL
Intervention: Surgery sparing the lower mediastinal lymph node dissection (LND)
Number of subjects: 634
Study: 39679006

Group type: EXPERIMENTAL
Intervention: Digital coaching (n=200)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care (n=400)
Number of subjects: 600
Study: 39679349

Group type: EXPERIMENTAL
Intervention: Third dose of 50 µg mRNA-1273
Number of subjects: 17000

Group type: COMPARATOR
Intervention: mRNA-1273 arm
Number of subjects: 17000

Group type: EXPERIMENTAL
Intervention: 15-month dosing interval
Number of subjects: 17000
Study: 39679566

Group type: EXPERIMENTAL
Intervention: Nonablative bipolar radiofrequency treatment
Number of subjects: 43
Study: 39679622

Group type: EXPERIMENTAL
Intervention: Intervention (ImPaC)
Number of subjects: 354
Study: 39679749

Group type: EXPERIMENTAL
Intervention: Multiple Micronutrients (MMN)
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: Small-Quantity Lipid-Based Nutrient Supplements (SQ-LNS)
Number of subjects: 965

Group type: COMPARATOR
Intervention: Iron and Folic Acid (IFA)
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: Home Environment Quality
Number of subjects: 965
Study: 39679979

Group type: EXPERIMENTAL
Intervention: Virtual community of practice (vCoP) intervention
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 282
Study: 39679985

Group type: EXPERIMENTAL
Intervention: Piano practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no piano practice)
Number of subjects: 0
Study: 39680321

Group type: EXPERIMENTAL
Intervention: 10 mg intravenous vitamin K1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 39680390

Group type: EXPERIMENTAL
Intervention: Ranibizumab (RIDE trial)
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: Ranibizumab (RISE trial)
Number of subjects: 759
Study: 39680397

Group type: EXPERIMENTAL
Intervention: Conditional social transfer
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Unconditional social transfer
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 298
Study: 39680398

Group type: EXPERIMENTAL
Intervention: Mobile application-based communication platform intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 151
Study: 39680411

Group type: EXPERIMENTAL
Intervention: CBD 400 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 39680511

Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 39680515

Group type: EXPERIMENTAL
Intervention: Adjunctive Steroid Combination in Ocular Trauma (ASCOT)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 259
Study: 39680874

Group type: EXPERIMENTAL
Intervention: Share plus intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: CGM Follow app plus diabetes self-management education
Number of subjects: 80
Study: 39680884

Group type: EXPERIMENTAL
Intervention: Self-guided OCD program on the mHealth app Intellect (8-day program)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Active control (cooperation)
Number of subjects: 225
Study: 39681072

Group type: EXPERIMENTAL
Intervention: Mother's own milk odor
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 39681126

Group type: EXPERIMENTAL
Intervention: Two-way SMS communication
Number of subjects: 360

Group type: COMPARATOR
Intervention: WhatsApp peer-support group
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Drug-level feedback counselling
Number of subjects: 360

Group type: COMPARATOR
Intervention: Monthly counselling
Number of subjects: 360
Study: 39681164

Group type: EXPERIMENTAL
Intervention: MAG-rich oil (up to 37 g/day) consumed three times daily for 13 days
Number of subjects: 24
Study: 39681397

Group type: EXPERIMENTAL
Intervention: Preoperative just-in-time expert intubation coaching on a manikin within one hour of infant intubation
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard practice (unstructured intraoperative instruction by attending pediatric anesthesiologists)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Preoperative just-in-time expert intubation coaching
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 153
Study: 39681752

Group type: EXPERIMENTAL
Intervention: Intraoral injection technique
Number of subjects: 42

Group type: COMPARATOR
Intervention: Extraoral injection technique
Number of subjects: 42
Study: 39681862

Group type: EXPERIMENTAL
Intervention: Family caregiver-targeted web-based psycho-educational intervention (videos and texts about family caregiving)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Family caregiver-targeted web-based psycho-educational intervention
Number of subjects: 39
Study: 39681893

Group type: EXPERIMENTAL
Intervention: Cellphone ownership
Number of subjects: 2019

Group type: COMPARATOR
Intervention: Daily cellphone access among non-cellphone owners
Number of subjects: 2019

Group type: EXPERIMENTAL
Intervention: Demographic and socioeconomic factors associated with cellphone ownership
Number of subjects: 2019
Study: 39681895

Group type: EXPERIMENTAL
Intervention: Nthabi conversational agent system for family planning education
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Nthabi conversational agent system for folic acid use education
Number of subjects: 172
Study: 39682637

Group type: EXPERIMENTAL
Intervention: Mobile app intervention with push notifications once a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no mobile app intervention)
Number of subjects: 0
Study: 39683419

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Probiotics with a healthy diet
Number of subjects: 92
Study: 39683612

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation for 12 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 160
Study: 39683619

Group type: EXPERIMENTAL
Intervention: Structured eating
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Impulsive or irregular eating patterns
Number of subjects: 720
Study: 39683633

Group type: EXPERIMENTAL
Intervention: 630 mg A-GPC (HD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 315 mg A-GPC (LD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study: 39684514

Group type: EXPERIMENTAL
Intervention: Plasma citrate levels in ESLD patients
Number of subjects: 129

Group type: COMPARATOR
Intervention: Plasma citrate levels in PREVEND participants
Number of subjects: 129
Study: 39684943

Group type: EXPERIMENTAL
Intervention: 2022 cohort
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: 2023 cohort
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Predictive model
Number of subjects: 833
Study: 39685557

Group type: EXPERIMENTAL
Intervention: Perioperative lung ultrasound findings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 39686459

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied to the affected shoulder and scapular regions
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 114
Study: 39686497

Group type: EXPERIMENTAL
Intervention: Tui-Na (TN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Positional Release Techniques (PRT)
Number of subjects: 50
Study: 39686569

Group type: EXPERIMENTAL
Intervention: HELIOSTAR multielectrode radiofrequency balloon catheter
Number of subjects: 257
Study: 39686614

Group type: EXPERIMENTAL
Intervention: Visit-to-visit blood pressure variability (BPV)
Number of subjects: 8034

Group type: EXPERIMENTAL
Intervention: Time in target range (TTR)
Number of subjects: 8034

Group type: EXPERIMENTAL
Intervention: Visit-to-visit BPV
Number of subjects: 8034
Study: 39686620

Group type: EXPERIMENTAL
Intervention: Gantenerumab (up to 1200 mg every 4 weeks)
Number of subjects: 154
Study: 39686647

Group type: EXPERIMENTAL
Intervention: Steroids alone or in combination with immunosuppressive drugs and/or IVIg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Microstructural damage in the corpus callosum
Number of subjects: 22
Study: 39686672

Group type: EXPERIMENTAL
Intervention: Portal vein pulsatility index
Number of subjects: 145
Study: 39686830

Group type: EXPERIMENTAL
Intervention: Erythritol powder air polishing (EPAP) followed by subgingival instrumentation 1 month later
Number of subjects: 22

Group type: COMPARATOR
Intervention: Scaling and root planing (control)
Number of subjects: 22
Study: 39687049

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS to the right DLPFC and intermittent theta burst stimulation (iTBS) to the cerebellum, delivered sequentially in 20 sessions along with antipsychotics.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham condition along with antipsychotics.
Number of subjects: 0
Study: 39687188

Group type: EXPERIMENTAL
Intervention: Indocyanine Green (ICG)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No-ICG (Control)
Number of subjects: 115
Study: 39687279

Group type: EXPERIMENTAL
Intervention: transcutaneous auricular vagus nerve stimulation (tVNS)
Number of subjects: 30
Study: 39687429

Group type: EXPERIMENTAL
Intervention: 3D-MOT-IVR intervention
Number of subjects: 10
Study: 39687431

Group type: EXPERIMENTAL
Intervention: Oral maintenance therapy with trofosfamide (2 × 75 mg/m²), etoposide, and idarubicin for 25 weeks (8 courses of 10 days each)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Standard treatment (S-arm)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 195
Study: 39687670

Group type: EXPERIMENTAL
Intervention: FIB-4 index
Number of subjects: 2726

Group type: EXPERIMENTAL
Intervention: FIB-4 index in FLI <30
Number of subjects: 2726

Group type: EXPERIMENTAL
Intervention: FIB-4 index in FLI 30-60
Number of subjects: 2726

Group type: EXPERIMENTAL
Intervention: FIB-4 index in FLI ≥60
Number of subjects: 2726

Group type: EXPERIMENTAL
Intervention: Interaction term for FIB-4 index with FLI ≥60 (reference FLI <30)
Number of subjects: 2726

Group type: EXPERIMENTAL
Intervention: Multivariable linear regressions
Number of subjects: 2726
Study: 39687787

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 1490

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1490
Study: 39688344

Group type: EXPERIMENTAL
Intervention: Line-field confocal optical coherence tomography (LC-OCT) combined with artificial intelligence (AI) algorithms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 39688408

Group type: EXPERIMENTAL
Intervention: Leritrelvir 400 mg
Number of subjects: 24
Study: 39688775

Group type: EXPERIMENTAL
Intervention: MiniMed™ 780G system
Number of subjects: 270
Study: 39688776

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (SGLT2i)
Number of subjects: 111
Study: 39688866

Group type: EXPERIMENTAL
Intervention: Standard tai ji quan
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Cognitively enhanced tai ji quan
Number of subjects: 318

Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 318
Study: 39689109

Group type: EXPERIMENTAL
Intervention: Horticultural Therapy (HT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Handiwork
Number of subjects: 16
Study: 39689129

Group type: EXPERIMENTAL
Intervention: Usual care plus STRATIFY intervention (web-based algorithm for risk stratification and matched interventions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 39689146

Group type: EXPERIMENTAL
Intervention: COACH intervention (six-month intervention including six monthly hypertension educational sessions, monthly blood pressure monitoring, follow up care coordination, fully subsidized antihypertensive medications, standardized treatment algorithm, training for providers)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: COACH intervention
Number of subjects: 100
Study: 39689189

Group type: EXPERIMENTAL
Intervention: Half-dose tenecteplase
Number of subjects: 390

Group type: COMPARATOR
Intervention: Full-dose tenecteplase
Number of subjects: 390

Group type: COMPARATOR
Intervention: Primary PCI
Number of subjects: 390
Study: 39689213

Group type: EXPERIMENTAL
Intervention: Combined native tissue vaginal prolapse repair with midurethral sling
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Colpocleisis (as a protective factor)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Higher body mass index
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Symptomatic stress urinary incontinence (SUI)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Charlson Comorbidity Index
Number of subjects: 254
Study: 39689188

Group type: EXPERIMENTAL
Intervention: Nuclear imaging (n=1532)
Number of subjects: 3601

Group type: EXPERIMENTAL
Intervention: Echocardiography (n=827)
Number of subjects: 3601

Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance imaging (n=108)
Number of subjects: 3601

Group type: EXPERIMENTAL
Intervention: Exercise tolerance test (n=1134)
Number of subjects: 3601
Study: 39689295

Group type: EXPERIMENTAL
Intervention: Morning high-intensity interval exercise (HIIE)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Evening high-intensity interval exercise (HIIE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No exercise control
Number of subjects: 26
Study: 39689939

Group type: EXPERIMENTAL
Intervention: 3-week home-based pulmonary rehabilitation (PR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 50
Study: 39689940

Group type: EXPERIMENTAL
Intervention: Threshold of 5 mm to 8 mm for 'MIA+IA'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 8 mm to 10 mm for 'MIA+IA'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 5 mm to 7 mm for 'MIA+IA'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 5 mm to 8 mm for 'AAH+AIS+MIA+IA'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 5 mm to 7 mm for 'IA-only'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 7 mm to 10 mm for 'MIA+IA'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 7 mm to 10 mm for 'AAH+AIS+MIA+IA'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 7 mm to 10 mm for 'IA-only'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold of 8 mm predictive model
Number of subjects: 0
Study: 39689944

Group type: EXPERIMENTAL
Intervention: Electrically heated mittens worn for at least 15 minutes daily for six weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control mittens (heating elements disconnected) worn for at least 15 minutes daily for six weeks
Number of subjects: 200
Study: 39689992

Group type: EXPERIMENTAL
Intervention: Targeted microwave ablation (TMA)
Number of subjects: 30
Study: 39690158

Group type: EXPERIMENTAL
Intervention: Rezvilutamide plus androgen deprivation therapy (REZ-ADT)
Number of subjects: 0
Study: 39690339

Group type: EXPERIMENTAL
Intervention: Flow Diverters (FDs)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional stent-assisted coiling
Number of subjects: 152
Study: 39690977

Group type: EXPERIMENTAL
Intervention: Referral by primary care clinicians (PCCs)
Number of subjects: 5322

Group type: EXPERIMENTAL
Intervention: Referred patients
Number of subjects: 5322
Study: 39691038

Group type: EXPERIMENTAL
Intervention: Genoss DES
Number of subjects: 483

Group type: COMPARATOR
Intervention: Orsiro stent
Number of subjects: 483
Study: 39691073

Group type: EXPERIMENTAL
Intervention: Vascular comorbidities (hypertension)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Vascular comorbidities (hyperlipidaemia)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Having ≥2 comorbidities
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Vascular comorbidities/comorbidity count
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Overall comorbidity burden
Number of subjects: 445
Study: 39691156

Group type: EXPERIMENTAL
Intervention: Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dual Therapies
Number of subjects: 0
Study: 39691173

Group type: EXPERIMENTAL
Intervention: Various intra-articular injections, oral opioid and nonopioid medications (including nonsteroidal anti-inflammatory drugs), cryo nerve blocks, radiofrequency ablations, novel treatment modalities, other physical therapy modalities (including muscle strengthening), and total knee arthroplasties.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Index joint-directed treatments
Number of subjects: 0
Study: 39691275

Group type: EXPERIMENTAL
Intervention: EORTC QLQ-CLL17 domain scores assessment
Number of subjects: 62
Study: 39691290

Group type: EXPERIMENTAL
Intervention: DAA treatment
Number of subjects: 402
Study: 39691584

Group type: EXPERIMENTAL
Intervention: Peer educator led ART refill model
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Peer educator led Saturday clinic club for ART collection
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: SMS reminders for treatment adherence and ART refill visits
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Support by peer educator
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Support by nurse without peer educator involvement
Number of subjects: 123
Study: 39691654

Group type: EXPERIMENTAL
Intervention: Chest ultrasound (CUS)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Computer-aided diagnosis (CAD)
Number of subjects: 136
Study: 39691721

Group type: EXPERIMENTAL
Intervention: scRNA-seq analysis on peripheral blood lymphocytes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent spot (ELISpot), cytokine production analysis, and T-cell proliferation assays
Number of subjects: 20
Study: 39691748

Group type: EXPERIMENTAL
Intervention: Lidocaine 5% white hydrogel plasters
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo control (plain hydrogel plasters)
Number of subjects: 180
Study: 39691747

Group type: EXPERIMENTAL
Intervention: Kinesiotaping plus standard analgesic treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard analgesic treatment
Number of subjects: 34
Study: 39691834

Group type: EXPERIMENTAL
Intervention: Artificial Intelligence of Medicine (AIMED) system using convolutional neural networks and MobileNetV3-large
Number of subjects: 16031
Study: 39692004

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 4 mg/kg (maximum 400 mg), single cycle
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Surgery after pembrolizumab treatment
Number of subjects: 42
Study: 39692213

Group type: EXPERIMENTAL
Intervention: Higher PlGF
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Higher FW
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: FW
Number of subjects: 370
Study: 39692262

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)-based mobile application
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 91
Study: 39692276

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercises with physiotherapist in primary care twice a week for 12 weeks and daily walks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Unsupervised home-based exercise including daily walks
Number of subjects: 90
Study: 39692401

Group type: EXPERIMENTAL
Intervention: Emicizumab prophylaxis
Number of subjects: 504
Study: 39692552

Group type: EXPERIMENTAL
Intervention: Early aerobic exercise treatment
Number of subjects: 56
Study: 39692702

Group type: EXPERIMENTAL
Intervention: STP705
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 8
Study: 39692742

Group type: EXPERIMENTAL
Intervention: Stump length measurement
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Berg Balance Scale
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Other muscle strength and proprioception parameters
Number of subjects: 16